Vorinostat in Treating Patients With Kidney Cancer

Summary

This phase II trial is studying how well vorinostat works in treating patients with advanced kidney cancer. Drugs used in chemotherapy, such as vorinostat, work in different ways to stop the growth of tumor cells, either by killing the cells or by stopping them from dividing. Vorinostat may also stop the growth of tumor cells by blocking blood flow to the tumor.

Timeline

Start

2005-10

Primary completion

2010-02

Completion

2010-02

Drugs

Indications